Ubiquinol is made in two fundamentally different ways depending on context. Inside your body, cells synthesize the parent molecule ubiquinone through a multi-step biochemical pathway and then reduce it enzymatically to ubiquinol. In the supplement industry, manufacturers typically use microbial fermentation to produce coenzyme Q10, then chemically reduce it to the ubiquinol form and stabilize it for encapsulation. The distinction between these two routes matters more than most supplement marketing suggests, because your body already converts between the two forms constantly and the real bottleneck is often production capacity, not which form you swallow.
How Your Body Produces Ubiquinol
Every human cell with mitochondria can make coenzyme Q10 from scratch. The process starts in the same biochemical pathway your body uses to make cholesterol. Cells assemble the molecule in two parts: a ring structure derived from the amino acid tyrosine, and a long lipid tail built from smaller units through a series of enzymatic reactions. The tail in humans is ten units long, which is why the molecule is called coenzyme Q10 (the “10” refers to these repeating units). Interestingly, rodents mainly produce coenzyme Q9, with a nine-unit tail, a difference that may have implications for how the molecule sits in mitochondrial membranes and how efficiently it manages free radicals.1PubMed. The effect of isoprenoid side chain length of ubiquinone on life span
What comes off the assembly line is ubiquinone, the oxidized form. Your cells then reduce it to ubiquinol using dedicated enzymes. This is not a one-time conversion. Ubiquinone and ubiquinol shuttle back and forth between their two forms constantly as part of the mitochondrial electron transport chain. In mitochondria, ubiquinone picks up electrons at Complex I or Complex II and becomes ubiquinol, then hands those electrons off at Complex III and reverts to ubiquinone. This cycling is the core of how your cells generate energy.2PubMed Central. The Ubiquinone-Ubiquinol Redox Cycle and Its Clinical Consequences: An Overview Enzymes outside the mitochondria also participate in this shuttling, meaning the conversion happens throughout the cell, not just in the energy-producing compartments.
Under normal conditions, this system keeps the vast majority of coenzyme Q10 in the reduced, ubiquinol form. Measurements of healthy human blood consistently show a ratio of roughly 95% ubiquinol to 5% ubiquinone.3PubMed. Plasma ratio of ubiquinol and ubiquinone as a marker of oxidative stress That ratio itself can serve as a window into oxidative stress: when the body is under heavy free-radical burden, the proportion of ubiquinone rises because ubiquinol is being consumed faster than it can be regenerated.
What Ubiquinol Actually Does Once It Exists
The constant conversion between forms is not just a byproduct of energy production. Each form has distinct jobs. In the mitochondrial respiratory chain, coenzyme Q10 acts as an electron carrier, ferrying electrons between protein complexes to drive the production of ATP, your cells’ energy currency. Research has shown that Q10 molecules appear to be organized into at least two functional pools within mitochondria: one tightly associated with the large super-complexes that do the heavy lifting of electron transport, and a free pool that serves other mitochondrial enzymes needing an electron shuttle.4PubMed Central. Metabolic Targets of Coenzyme Q10 in Mitochondria
Outside this energy role, ubiquinol specifically functions as a powerful lipid-soluble antioxidant. It sits within cell membranes and lipoproteins in the blood, where it scavenges free radicals that would otherwise damage fats. Research has found that ubiquinol is roughly as effective at preventing oxidative damage to lipids as vitamin E, which has long been considered the gold standard for fat-soluble antioxidant protection.5PubMed Central. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations This dual identity, energy carrier and antioxidant, is what makes coenzyme Q10 levels matter so much to cellular health.
Why Your Body’s Production Declines
Coenzyme Q10 levels in human tissues do not stay constant over a lifetime. They fall with age, though the decline is uneven across organs and not universal to all species.6PubMed Central. CoQ10 and Aging The heart and brain, organs with intense energy demands, are thought to be particularly affected, which is part of why CoQ10 has attracted so much interest in cardiovascular and neurological research. The reasons for the decline are not fully pinned down but likely involve reduced expression of the biosynthetic enzymes as cells age.
Medications can accelerate this drop substantially. Statins, prescribed to tens of millions of people worldwide for cholesterol management, work by blocking a step in the same metabolic pathway the body uses to make coenzyme Q10. In one study, patients taking atorvastatin saw their blood CoQ10 levels fall by roughly half within 30 days, with a significant decrease detectable after just two weeks.7PubMed. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke This connection has been studied more granularly in skeletal muscle tissue, where statin treatment has been associated with reduced ubiquinone levels and impaired activity of mitochondrial complex IV, one of the downstream enzymes that depends on adequate coenzyme Q10.8PubMed. Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment Whether this mechanism explains the muscle pain some statin users report remains debated, but it is one of the more plausible candidates.
Rarer but more severe are primary CoQ10 deficiencies caused by genetic mutations. Mutations in at least eight genes involved in the biosynthetic pathway can cause these conditions, which range from fatal multi-organ disease in infancy to kidney or neurological problems appearing as late as the seventh decade of life. High-dose supplementation can halt progression in some forms, making early diagnosis critical.9PubMed. Genetic bases and clinical manifestations of coenzyme Q10 (CoQ 10) deficiency
How Supplement Ubiquinol Is Manufactured
The industrial production of coenzyme Q10 has evolved considerably since the compound first attracted commercial interest. Three broad approaches exist: chemical synthesis, semi-synthetic methods, and microbial fermentation. Chemical synthesis uses precursor molecules to build the CoQ10 structure from the ground up. Semi-synthetic methods start with a natural intermediate and finish the job chemically. But microbial fermentation has become the dominant commercial method, in large part because it yields the molecule in the correct three-dimensional configuration that the body recognizes.10PubMed Central. CoQ10 a super-vitamin: review on application and biosynthesis
In fermentation, specific strains of bacteria or yeast that naturally produce high levels of CoQ10 are grown in large bioreactors. The organisms are fed inexpensive nutrients and left to do what they do naturally, synthesize coenzyme Q10 as part of their own metabolism. The CoQ10 is then extracted, purified, and, if the product is sold as ubiquinol, chemically reduced from its oxidized (ubiquinone) state to the reduced (ubiquinol) form. Researchers have also explored genetically engineering organisms like E. coli and Agrobacterium tumefaciens to boost CoQ10 yields further, as understanding of the biosynthetic enzymes has improved.11PubMed. Current state of coenzyme Q(10) production and its applications
Stabilizing ubiquinol for encapsulation is a genuine engineering challenge. Ubiquinol is inherently unstable, it wants to donate its electrons and revert to ubiquinone when exposed to oxygen, heat, or light. Supplement manufacturers address this by dissolving ubiquinol in carrier lipids inside sealed soft-gel capsules, often with added antioxidants like vitamin C to protect the reduced form during shelf life. The quality of the carrier lipid and the sealing matter: poorly formulated products can contain substantially oxidized CoQ10 by the time you open the bottle, even if they started as ubiquinol.
How Much Ubiquinol Comes from Food
Before anyone reaches for a supplement, it is worth knowing that you already eat both ubiquinol and ubiquinone in food. A Japanese study analyzing 70 food items found ubiquinol in 63 of them. Meat, organ meats, and oily fish are the richest sources. Pork shoulder, bovine liver, chicken heart, horse mackerel, young yellowtail, and soybean oil all contained more than 20 micrograms of ubiquinol per gram. Vegetables, fruits, and grains contain much less, generally below 6 micrograms per gram.12Journal of Food Composition and Analysis. Food content of ubiquinol-10 and ubiquinone-10 in the Japanese diet
Based on typical Japanese food consumption patterns, the estimated average daily intake came to about 2 milligrams of ubiquinol and about 4.5 milligrams of total coenzyme Q10, meaning ubiquinol accounted for about 46% of dietary CoQ10. These are tiny amounts compared to supplement doses, which commonly range from 100 to 400 milligrams. Dietary intake alone is unlikely to move the needle if your body’s own production has fallen substantially, whether from aging, medication, or genetic variation. But for healthy younger adults, diet plus endogenous production generally covers the body’s needs without supplementation.
Ubiquinol vs. Ubiquinone Supplements
This is the question supplement shoppers spend the most time on, and the answer is less dramatic than the marketing implies. Ubiquinol supplements are sold at a premium with the claim that the reduced form is better absorbed, and there is some laboratory evidence to support this. Cell culture and digestion-simulation experiments have shown that ubiquinol is more efficiently incorporated into the mixed micelles that form during digestion, and that intestinal cells take it up and transport it more readily than ubiquinone, through a mechanism that depends on the antioxidant glutathione.13Journal of Agricultural and Food Chemistry. Increased Bioavailability of Ubiquinol Compared to That of Ubiquinone Is Due to More Efficient Micellarization during Digestion and Greater GSH-Dependent Uptake and Basolateral Secretion by Caco‑2 Cells
But when researchers compared well-formulated soft-gel capsules of ubiquinone and ubiquinol head to head in actual human volunteers, the plasma CoQ10 profiles were similar. The formulation, particularly the carrier lipid the CoQ10 was dissolved in, mattered at least as much as the oxidation state of the molecule.14ScienceDirect. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization This makes sense when you remember that the body maintains a 95:5 ubiquinol-to-ubiquinone ratio in the blood. Whatever form you swallow, intestinal and liver enzymes quickly reduce ubiquinone to ubiquinol anyway. A well-designed ubiquinone soft-gel dissolved in an appropriate oil can be just as effective as a ubiquinol product, and the ubiquinone version is typically cheaper and more shelf-stable.
The practical takeaway: if you are a generally healthy person, the form probably matters less than the formulation. If you are older or have a condition that impairs your body’s reducing capacity (meaning you are less efficient at converting ubiquinone to ubiquinol), the reduced form could offer a marginal advantage. But paying two or three times the price for ubiquinol over a high-quality ubiquinone product is hard to justify based on current evidence.
What Happens When You Take Ubiquinol Supplements
CoQ10 is fat-soluble, so absorption improves when you take it with a meal that contains some dietary fat. After you swallow a ubiquinol capsule, it passes through the stomach and reaches the small intestine, where the carrier lipid helps it mix into digestive micelles. These micelles deliver it to the cells lining the intestine, which absorb the ubiquinol and package it into lipoproteins for release into the bloodstream. A typical ubiquinol soft-gel reaches peak blood levels about six to eight hours after ingestion, with levels gradually declining back to baseline over the following day or two.
Once in the blood, CoQ10 hitches a ride mainly on LDL and VLDL lipoproteins, traveling to tissues throughout the body. The heart, liver, kidneys, and skeletal muscles, all high-energy tissues, take up the most. Whether supplemental CoQ10 actually reaches the mitochondria inside cells in meaningful amounts has been harder to demonstrate in humans, and this remains one of the open questions in the field. Blood levels rise reliably with supplementation, but matching that to tissue-level changes requires biopsy data that is scarce outside of specialized clinical settings.
Clinical Evidence for Ubiquinol Supplementation
Most of the large clinical trials on coenzyme Q10 used the ubiquinone form, simply because it was available first and is easier to work with. Ubiquinol-specific trials are fewer but growing. In one randomized controlled trial of elderly patients undergoing aortic valve replacement surgery, ubiquinol supplementation counteracted the drop in plasma CoQ10 that normally follows such surgery. Patients receiving ubiquinol also had lower levels of troponin I, a marker of heart muscle damage, after the procedure, and showed better recovery of heart pumping function compared to the placebo group.15PubMed Central. Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects
In a separate small crossover study of patients with heart failure, ubiquinol at 400 milligrams per day for three months improved a measure of blood vessel function that reflects endothelial health. The improvement was statistically significant with ubiquinol but not with placebo.16PubMed. Ubiquinol Improves Endothelial Function in Patients with Heart Failure with Reduced Ejection Fraction: A Single-Center, Randomized Double-Blind Placebo-Controlled Crossover Pilot Study These are encouraging signals, but both studies were small and focused on specific cardiac populations. Extrapolating them to healthy people taking ubiquinol for general wellness would be a stretch.
The broader CoQ10 literature, including the larger trials using ubiquinone, paints a picture of a supplement that is generally safe, well tolerated at doses up to several hundred milligrams per day, and shows the most consistent benefits in people who are genuinely CoQ10-depleted, whether from statin therapy, genetic conditions, or advanced heart failure. For people whose endogenous production is normal, evidence of meaningful benefit is much thinner.
Formulation Details That Actually Matter
If you do decide to supplement, a few practical details affect whether you get what you are paying for:
- Carrier lipid: CoQ10 needs to be dissolved in oil to absorb well. Dry powder capsules or tablets without a lipid matrix deliver less to the bloodstream than soft-gel capsules where the CoQ10 is already dissolved.
- Solubilization: Some manufacturers use proprietary processes to break the CoQ10 into smaller particles or dissolve it more thoroughly in the carrier oil. This can improve absorption regardless of whether the product is ubiquinol or ubiquinone.
- Packaging and storage: Ubiquinol is sensitive to oxygen and light. Products in opaque, tightly sealed soft-gel capsules stored in cool, dark conditions are more likely to still be in the reduced form when you take them.
- Third-party testing: Because the CoQ10 supplement market is large and loosely regulated in many countries, products vary widely in actual content versus label claims. Independent testing services have found some products contain significantly less CoQ10 than advertised.
The formulation findings reinforce a counterintuitive point: a well-made ubiquinone soft-gel can outperform a poorly made ubiquinol product. Shopping by form alone and ignoring the underlying formulation quality is one of the more common mistakes consumers make.
Cross-Species Differences in Coenzyme Q
Humans are not the only organisms that make coenzyme Q, and the variants across species offer some intriguing biology. While humans and other primates produce Q10 (with a 10-unit isoprenoid tail), rodents predominantly make Q9 (with a 9-unit tail). This difference is not cosmetic. The length of the tail influences how deeply the molecule embeds itself in the inner mitochondrial membrane. A hypothesis that has attracted attention proposes that shorter-tailed versions like Q9 leave the semiquinone intermediate (the halfway-reduced form) more exposed to the watery environment on either side of the membrane, potentially generating more damaging superoxide radicals.1PubMed. The effect of isoprenoid side chain length of ubiquinone on life span Whether this genuinely explains the shorter lifespans of rodents compared to primates is far from settled, but it is a reminder that the specifics of the coenzyme Q molecule, down to its tail length, carry biological consequences that go well beyond simple antioxidant chemistry.
Bacteria use even shorter-tailed versions, which is one reason microbial fermentation for supplement production requires carefully selected strains. Only certain bacteria naturally produce the Q10 form that matches the human molecule. Genetic engineering efforts aim to push organisms like E. coli, which naturally make shorter-chain coenzyme Q, toward producing the longer Q10 version in commercially viable quantities. The field is still evolving, and advances in synthetic biology may eventually make fermentation-based production cheaper and more efficient, potentially bringing down the cost of both ubiquinone and ubiquinol supplements.